67 related articles for article (PubMed ID: 20960713)
1. [The peculiarities of esophageal epithelium of the vertebrates in phylogenesis and Barrett's esophagus].
Mogil'naia GM; Driaeva LG; Durleshter VM; Mogil'naia VL
Morfologiia; 2010; 137(3):41-5. PubMed ID: 20960713
[TBL] [Abstract][Full Text] [Related]
2. Mucin histochemistry of intestinal metaplasia in Barrett's esophagus.
Jauregui HO; Davessar K; Hale JH; Kessimian N; Cenoz C
Mod Pathol; 1988 May; 1(3):188-92. PubMed ID: 3237699
[TBL] [Abstract][Full Text] [Related]
3. Mucin histochemistry in Barrett's esophagus.
Sirigu F; Capeccioni S; Dessì A
Riv Eur Sci Med Farmacol; 1990; 12(4-5):229-32. PubMed ID: 2103960
[TBL] [Abstract][Full Text] [Related]
4. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
10. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
11. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
Byrne JP; Armstrong GR; Attwood SE
Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
[TBL] [Abstract][Full Text] [Related]
13. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of multilayered epithelium in Barrett's esophagus.
Shields HM; Rosenberg SJ; Zwas FR; Ransil BJ; Lembo AJ; Odze R
Am J Gastroenterol; 2001 Dec; 96(12):3268-73. PubMed ID: 11774935
[TBL] [Abstract][Full Text] [Related]
15. Histological and anatomic changes in Barrett's esophagus after antireflux surgery.
Low DE; Levine DS; Dail DH; Kozarek RA
Am J Gastroenterol; 1999 Jan; 94(1):80-5. PubMed ID: 9934735
[TBL] [Abstract][Full Text] [Related]
16. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
Hepatogastroenterology; 2001; 48(42):1662-4. PubMed ID: 11813596
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
18. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
[TBL] [Abstract][Full Text] [Related]
19. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
20. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]